Gwenaël Primas

Statistics

Publications

Citations

128

H-Index

Active since

2014

Affiliations

Max Planck Institute of Experimental Medicine(Current)

Pharnext (France)

University of Göttingen

Gwenaël Primas is an author at Max Planck Institute of Experimental Medicine specializing in pharmacology, molecular neurobiology, and neurodegenerative diseases.

Publications per year

2014–2020

Publications

Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy

Ilya Chumakov, Aude Milet, Nathalie Cholet et al. · Orphanet Journal of Rare Diseases · 2014 · 105 citations · Full text

Medicine, Neurology, Pharmacology +15

Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats

Thomas Prukop, Stephanie Wernick, Lydie Boussicault et al. · Journal of Neuroscience Research · 2020 · 23 citations · Full text

Medicine, Neuroscience, Pharmacology +13

1–2 of 2